Recent Finacing
Recent Raise
NGM Biopharmaceuticals is a South San Francisco–based biotech that uses a proprietary post-genomic discovery platform—mining gastric bypass–related gene changes—to develop therapeutics (e.g., aldafermin, NGM120) for metabolic and cardio-metabolic diseases.
